188 related articles for article (PubMed ID: 23457501)
1. The association between MTHFR gene polymorphisms and hepatocellular carcinoma risk: a meta-analysis.
Qin X; Peng Q; Chen Z; Deng Y; Huang S; Xu J; Li H; Li S; Zhao J
PLoS One; 2013; 8(2):e56070. PubMed ID: 23457501
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of MTHFR C677T and A1298C gene polymorphisms: association with the risk of hepatocellular carcinoma.
Qi YH; Yao LP; Cui GB; Liang J; Shao QJ; Yan LF; Du P
Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):172-80. PubMed ID: 24316043
[TBL] [Abstract][Full Text] [Related]
3. Significant association between the MTHFR A1298C polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Chang W; Meng Q; Liu JH; Wu LX; Chen Y; Chen SD
Genet Mol Res; 2015 Dec; 14(4):15972-80. PubMed ID: 26662389
[TBL] [Abstract][Full Text] [Related]
4. Associations between methylenetetrahydrofolate reductase polymorphisms and hepatocellular carcinoma risk in Chinese population.
Qi X; Sun X; Xu J; Wang Z; Zhang J; Peng Z
Tumour Biol; 2014 Mar; 35(3):1757-62. PubMed ID: 24385382
[TBL] [Abstract][Full Text] [Related]
5. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J
Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
[TBL] [Abstract][Full Text] [Related]
6. Methylenetetrahydrofolate reductase C677T (Ala>Val, rs1801133 C>T) polymorphism decreases the susceptibility of hepatocellular carcinoma: a meta-analysis involving 12,628 subjects.
Zhang S; Jiang J; Tang W; Liu L
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32010931
[TBL] [Abstract][Full Text] [Related]
7. MTHFR C677T, A1298C and MS A2756G Gene Polymorphisms and Male Infertility Risk in a Chinese Population: A Meta-Analysis.
Ren Z; Ren P; Yang B; Fang K; Ren S; Liao J; Liu S; Liu L; Peng Z; Dong Q
PLoS One; 2017; 12(1):e0169789. PubMed ID: 28081209
[TBL] [Abstract][Full Text] [Related]
8. Association between maternal, fetal and paternal MTHFR gene C677T and A1298C polymorphisms and risk of recurrent pregnancy loss: a comprehensive evaluation.
Yang Y; Luo Y; Yuan J; Tang Y; Xiong L; Xu M; Rao X; Liu H
Arch Gynecol Obstet; 2016 Jun; 293(6):1197-211. PubMed ID: 26530235
[TBL] [Abstract][Full Text] [Related]
9. Association between methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C polymorphisms and essential hypertension: a systematic review and meta-analysis.
Wu YL; Hu CY; Lu SS; Gong FF; Feng F; Qian ZZ; Ding XX; Yang HY; Sun YH
Metabolism; 2014 Dec; 63(12):1503-11. PubMed ID: 25458833
[TBL] [Abstract][Full Text] [Related]
10. Association between MTHFR gene polymorphisms (C677T, A1298C) and genetic susceptibility to prostate cancer: a meta-analysis.
Chen PL; Li WT; Wang J; Jiang YD; Wu P; Chen T; Zheng SB
Genet Mol Res; 2015 Dec; 14(4):19191-202. PubMed ID: 26782572
[TBL] [Abstract][Full Text] [Related]
11. Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and the risk of primary hepatocellular carcinoma (HCC) in a Chinese population.
Mu LN; Cao W; Zhang ZF; Cai L; Jiang QW; You NC; Goldstein BY; Wei GR; Chen CW; Lu QY; Zhou XF; Ding BG; Chang J; Yu SZ
Cancer Causes Control; 2007 Aug; 18(6):665-75. PubMed ID: 17503006
[TBL] [Abstract][Full Text] [Related]
12. Associations between methylenetetrahydrofolate reductase polymorphisms and hepatocellular carcinoma risk: An update meta-analysis and trial sequential analysis.
Wang B; Ma M; Guo X; Yan Y; Li L
Medicine (Baltimore); 2021 Oct; 100(41):e27527. PubMed ID: 34731145
[TBL] [Abstract][Full Text] [Related]
13. Significant association between MTHFR C677T polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Sun H; Han B; Zhai H; Cheng X; Ma K
Tumour Biol; 2014 Jan; 35(1):189-93. PubMed ID: 24132589
[TBL] [Abstract][Full Text] [Related]
14. The polymorphism of methylenetetrahydrofolate reductase C677T but not A1298C contributes to gastric cancer.
Lv L; Wang P; Sun B; Chen G
Tumour Biol; 2014 Jan; 35(1):227-37. PubMed ID: 23897558
[TBL] [Abstract][Full Text] [Related]
15. Association of methylenetetrahydrofolate reductase (
Yang R; Pu D; Tan R; Wu J
Arch Endocrinol Metab; 2022 Sept 08; 66(4):551-581. PubMed ID: 35758831
[TBL] [Abstract][Full Text] [Related]
16. A meta-analysis of the relationship between MTHFR gene A1298C polymorphism and the risk of adult stroke.
Zhang MJ; Hu ZC; Yin YW; Li BH; Liu Y; Liao SQ; Gao CY; Li JC; Zhang LL
Cerebrovasc Dis; 2014; 38(6):425-32. PubMed ID: 25472665
[TBL] [Abstract][Full Text] [Related]
17. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and susceptibility for cervical lesions: a meta-analysis.
Long S; Yang X; Liu X; Yang P
PLoS One; 2012; 7(12):e52381. PubMed ID: 23285018
[TBL] [Abstract][Full Text] [Related]
18. TP53 and MDM2 gene polymorphisms, gene-gene interaction, and hepatocellular carcinoma risk: evidence from an updated meta-analysis.
Peng Q; Lao X; Chen Z; Lai H; Deng Y; Wang J; Mo C; Sui J; Wu J; Zhai L; Yang S; Qin X; Li S
PLoS One; 2013; 8(12):e82773. PubMed ID: 24376578
[TBL] [Abstract][Full Text] [Related]
19. Quantitative assessment of the associations between MTHFR C677T and A1298C polymorphisms and risk of fractures: a meta-analysis.
Bai R; Liu W; Zhao A; Zhao Z; Jiang D
Mol Biol Rep; 2013 Mar; 40(3):2419-30. PubMed ID: 23229495
[TBL] [Abstract][Full Text] [Related]
20. The association between MTHFR polymorphisms and cervical cancer risk: a system review and meta analysis.
Yi K; Yang L; Lan Z; Xi M
Arch Gynecol Obstet; 2016 Sep; 294(3):579-88. PubMed ID: 26879954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
